A Phase I Study Of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Alvespimycin (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 19 Aug 2005 New trial record.
- 19 Aug 2005 New trial record.